C. O. Truxton Recalls Phenobarbital Tablets Due to Labeling Error
C. O. Truxton is recalling specific lots of Phenobarbital Tablets USP, 30 mg, because they may be mislabeled. The FDA classifies this as a Class I recall.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA has classified this recall as Class I, which indicates a reasonable probability that use of or exposure to the violative product will cause serious adverse health consequences or death. Per the rubric, FDA Class I recalls are assigned a score of 4 or higher.
Plain-English summary
C. O. Truxton is recalling Phenobarbital Tablets USP, 30 mg, 1000 count bottles. The product is manufactured by West-ward Pharmaceutical Corp. and distributed by Truxton, Inc. The recall is due to a labeling error where the product may be mislabeled.
The FDA has classified this recall as Class I. The affected lots are # 70926A (Exp. 11/17), # 70981A (Exp. 01/18), and # H15A59 (Exp. 08/18). The NDC for the product is 0463-6145-10. The distribution pattern is listed as nationwide.
Consumers and healthcare providers should check their inventory for these specific lot numbers and expiration dates. If the product is found, it should be returned to the distributor or disposed of according to local regulations. Patients should consult their healthcare provider for alternative medication if necessary.
The recalled product
- Product
- Phenobarbital Tablets USP, 30 mg, 1000 count bottles, Rx Only, Manufactured by West-ward Pharmaceutical Corp. Eatontown, NJ 07724, Distributed by Truxton, Inc., Bellmawr, NJ 08031, NDC 0463-6145-10
- Manufacturer
- C. O. Truxton
- Category
- Drug — Prescription Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot # 70926A
- Exp. 11/17 Lot # 70981A
- Exp. 01/18 Lot # H15A59
- Exp. 08/18
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 6 recalled by C. O. Truxton under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · C. O. Truxton
See all →- CriticalPhenobarbital Tablets Recalled Due to Incorrect Strength Labeling
FDA (Drugs) · 2017-08-30
- ModerateC. O. Truxton Recalls Phenobarbital Tablets Due to Labeling Error
FDA (Drugs) · 2017-08-30
- ModerateC. O. Truxton Recalls Mislabeled Amitriptyline HCL Tablets
FDA (Drugs) · 2017-08-30
- ModerateC. O. Truxton Recalls Phenobarbital Tablets Due to Labeling Error
FDA (Drugs) · 2017-08-30
- ModeratePhenobarbital Tablets Recalled for Potential Labeling Errors
FDA (Drugs) · 2017-08-30
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- LowWest-ward Recalls Carisoprodol Tablets for Missing C-IV Labeling
FDA (Drugs) · 2013-03-27
- ModerateC. O. Truxton Recalls Doxycycline Hyclate Tablets Due to Wrong Bar Code
FDA (Drugs) · 2015-11-18
- LowUpsher Smith Recalls Oxandrolone Tablets Due to Missing Primary Labels
FDA (Drugs) · 2014-04-30
- SevereFDA Recalls Phenobarbital Tablets Due to Potential Pregabalin Labeling Error
FDA (Drugs) · 2014-01-29
- LowSandoz Recalls Lisinopril Tablets Due to Missing Package Insert
FDA (Drugs) · 2016-06-22
- SevereSpironolactone Tablets Recalled Due to Potential Labeling Error
FDA (Drugs) · 2021-03-24